Company: SHPH
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0001641172-25-010964
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item
5.07 Submission of Matters to a Vote of Security Holders.

On
May 9, 2025, the Company held its virtual 2025 Annual Meeting of Stockholders Meeting (the “ Meeting

As
of March 13, 2025, the record date for the Meeting, there were 6,257,693 shares of the Company’s common stock issued and outstanding,
with each share entitled to one vote on each proposal at the Meeting. At the Meeting, the combined holders of 4,178,024 shares of the
voting stock entitled to vote at the Meeting were represented in person or by proxy, representing approximately 66.8% of the outstanding
shares, and thereby a quorum was present for the Meeting.

The
final results for each of the matters considered at the Meeting were as follows:

Proposal
No. 1: Election of Directors

  Name                Votes        Votes       Withheld         Broker  
                        For      Against                     Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  Anatoly         2,619,600            0        480,017      1,078,407  
  Steven          2,619,666            0        482,951      1,078,407  
  George          1,893,996            0      1,205,621      1,078,407  
  Oleh            2,428,743            0        670,874      1,078,407  
  Joseph          1,892,605            0      1,207,012      1,078,407  

A
plurality of the votes cast is required for election of directors.. Accordingly, Proposal 1 was approved and each of the five nominees
elected at the Meeting will commence their term at the end of the Meeting and serve until the next Meeting, or until a successor has
been elected and qualified, or until such director’s earlier resignation or removal. As indicated in Item 5.02, Dr. Anatoly Dritschilo
tendered his resignation after the Meeting from his role as Chief Scientific Offer and director effective immediately.

Proposal
No. 2: Ratification of Appointment of Forvis Mazars, LLP as the Company’s Independent Registered Public Accounting Firm

      Votes        Votes      Abstentions/Withheld  
        For      Against                            
 ─────────────────────────────────────────